Is healthcare choice being eroded to an all-time low?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.395, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Healthcare: time for the public to do its bit?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 293, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?

By Bala M.V.

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 495-498

Adis International

Access to resources Recommend Favorite

Not all glitazones tarnished by hepatotoxicity?

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

All smoke and no fire with amfebutamone?

Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Is the US getting value for its healthcare dollar?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite